History
We, 2023~2024: Discovery Part: DEL (DNA Encoded Library), Proteomics built in house
We, 2025: Build 5 clinical pipelines
Our challenge continues to make an innovative history of new drug development.

2022
02
Series B Closing
2021
05
Elected for Data Voucher Business (Korea Data Agency)
07
Elected for R&D Investment Infrastructure linked Government Project (Korea Health Industry Development Institute, KHIDI)
10
Tech Credit Bureau (TCB): TI- Third grade
04
Established Proteolytic Drug Research Center (Gwanggyo, Gyeonggi-do)

03
Bridge funding (Undisclosed)
2020
05
Received the Grand Prize in PROTAC New Drug (2020 Korea Industry Best Enterprise Award)
2019
11
Received Venture Business Certification (2019-2024)
08
Series A (Undisclosed)
07
Flip between Pin US & Pin Therapeutics
2018
08
Join in JLABS at South San Francisco
03
Pin Therapeutics Korea established (renamed as Pin Therapeutics)

2017
11
Pre-series A (Undisclosed)
02
Pin therapeutics founded (Bay area, USA)